Ecraid

Our Education Newsletter is out now! Packed with opportunities and inspiration for early-career researchers and beyond: upcoming postgraduate courses, new scientific papers, a webinar recording you may have missed, & more resources to boost your knowledge 👉 mailchi.mp/ecraid/ecrai...

Don't miss this chance to attend this course featuring insightful lectures, interactive afternoon workshops and invaluable network opportunities with other researchers and experts from across Europe & beyond
👇
www.escmid.org/event-detail...

@escmid.bsky.social @umcutrecht.bsky.social

We are looking for a visionary Chief Executive Officer to lead Ecraid into its new chapter. If you are a purpose-driven and people-centred leader with bold ideas, an entrepreneurial spirit and a pan-European mindset, we’re looking for you!
More info 👉 www.ecraid.eu/careers

@idsky.bsky.social @academicsky.org @medsky.social

📩In our latest newsletter you can read more about our upcoming educational opportunities and get the latest updates on publications and study milestones.

👉🏽We're hiring a Chief Executive Officer! Are you interested? Read more in our newsletter.

📫Stay informed, subscribe now: bit.ly/07NewsEcraid

What are ethical, administrative, regulatory and logistical hurdles for delivery of RCTs & can these be qualified? Hot off the presses, this article in @jamanetworkopen.com by Dr.@denisevanhout.bsky.social, the REMAP-CAP investigators & the Ecraid operational team: jamanetwork.com/journals/jam...

Very pleased to announce a new speaker at our 'Better Methods' course in Athens: Prof. Sotirios Tsiodras! The programme will be updated shortly to reflect his topic.
Registration remains open for this unique learning experience for early-career investigators: www.escmid.org/event-detail...

💡New publication!
Researchers from #ECRAIDBase and ADVANCE-ID (NUS) have co-authored an article analysing the Personalised Randomised Controlled Trial (#PRACTicalTrial) design.
📖 bit.ly/45GgWUT
#ResearchCollaboration #HORIZON2020
@advance-id.bsky.social @horizoneu.bsky.social @hug-ge.bsky.social

@escmid.bsky.social @gardp.bsky.social @jesusrbano.bsky.social‬ @mariskaleeflang.bsky.social

#DKY that in our post-grad course you can choose between two tracks, join parallel workshops, discuss real-world cases, & network with your peers? 💡

👀Check out the programme, apply for an attendance grant, or register directly to secure your place!

➡️ bit.ly/44a1tdn

#IDSky #ResearchSky #Education

Proud of our partners at University of Geneva for having published an ECRAID-Base article investigating additional analysis methods for the novel Personalised Randomised Controlled Trial (PRACTical) design in @springernature.com:

👉 www.ecraid.eu/projects/ecr...

REMAP-CAP has published a paper in @springernature.com's Intensive Care Medicine Journal investigating whether hydrocortisone improves mortality in severe community-acquired pneumonia 👉 link.springer.com/article/10.1...
#Pneumonia #ClinicalTrials #REMAPCAP

@academicsky.org @idsky.bsky.social @infectiousdz.bsky.social #ClinicalResearch #InfectiousDiseases #NewCollaborations #Education #KnowledgeSharing

📩Check our latest newsletter for: highlights from our recent meeting with key primary care representatives, new collaborations (VAC4EU) and upcoming educational opportunities.
👉🏽Registration is open for the Postgraduate course in Athens!

📫Stay informed, subscribe now: bit.ly/EcraidJune25

@academicsky.org @infectiousdiseases.bsky.social @idsky3.bsky.social #ClinicalResearch #InfectiousDiseases #NewCollaborations #Education #KnowledgeSharing

#warmbasenetwork #hospitalnetwork #clinicalresearch

Diagnosing & treating infections in #ICUs is complex due to the need for rapid intervention and growing antibiotic resistance. Our head of CLIN-Net Miranda Hopman is at the Intensive Medicine Congress in Lisbon to discuss future collabos & share expertise on building a 'warm-base' research network.

Join this webinar organised by Ecraid & the European Respiratory Society, tackling adaptive clinical trials designs in the setting of a respiratory infection.

Info & registration 👉 ecraid.eu/news/webinar...

This webinar concludes the Ecraid Training Modules on Adaptive Clinical Trial Designs.

👩‍🍼 Every year, ~400k babies in Europe are born preterm and require admission to a NICU. Ecraid is proud to be part of the #NeoDeco study, which aims to determine if optimised #kangaroocare can reduce resistant bacterial colonization, severe #neonatalinfections and #sepsis in preterm infants in NICUs.

@escmid.bsky.social @taescmid.bsky.social @gardp.bsky.social @umcutrecht.bsky.social

Postgraduate course on Better Methods for clinical studies in infectious diseases and clinical microbiology. Grants available.

Are you an early-career investigator in #InfectiousDiseases or #ClinicalMicrobiology? This course might benefit you!
Expand your expertise & your network!

Focus: new developments in methods; special emphasis on clinical trials; & use participants’ projects as examples.

👉 ecraid.eu/news/postgra...

@ec.europa.eu @umcutrecht.bsky.social @ox.ac.uk @ecrin.bsky.social @oxprimarycare.bsky.social @christophercbutler.bsky.social
@vcstx.bsky.social @marcbonten.bsky.social #horizon2020
#respiratoryillness #Flu #ClinicalResearch #ECRAIDBase #ECRAIDPrime

💡 Why is a strong #primarycare research network critical to Europe’s response? Because it brings research closer to communities - enabling faster, smarter & more coordinated action when it matters most.

Read about Europe’s primarycare network & its recent meeting on 🔗 www.ecraid.eu/news/collabo...

🎙️Join this live #REVIVE webinar from @gardp.bsky.social on post-licensing clinical trials for advancing the use of antimicrobials - moderated by Ecraid's STAT-Net Holly Jackson from Geneva University Hospital!

Will you tune in? 🎧

The world celebrates International Clinical Trials Day to commemorate research professionals. 🔬

👉🏽Ecraid plays a key role in ID research and today we’re featuring the valued members of our operations team. Our teams are powered by the commitment of driving clinical research forward! #CTD2025

Ecraid and VAC4EU collaborate to strengthen vaccine research and monitoring of risk and benefits | Ecraid

We’re excited to collaborate with VAC4EU to advance #vaccineresearch. The new partnership will assess the potential of leveraging our ongoing #observationalstudies to evaluate #vaccineeffectiveness and real-world impact.
💉 www.ecraid.eu/news/ecraid-...

#clinicalresearch #vaccines

@idsky.bsky.social @medsky.social @academicsky.org @infectiousdz.bsky.social

📩Our May newsletter highlights the inspiring conversations with the research community at ESCMID Global & Ecraid's scientific contributions in the field of ID.
❗Educational opportunity: registration is open for the Postgraduate course. Check it out!
Stay informed, subscribe now: bit.ly/May-News-25

🩺 Happy Nurses Day! 💙

We are incredibly grateful for the nurses who work alongside us. Be it caring for patients in clinical trials, ensuring ethical standards, or contributing to life-saving discoveries, your impact is immeasurable!

#NursesDay #ClinicalResearch

@ec.europa.eu @umcutrecht.bsky.social @ox.ac.uk @ecrin.bsky.social @oxprimarycare.bsky.social @christophercbutler.bsky.social
@vcstx.bsky.social @marcbonten.bsky.social #horizon2020
#respiratoryillness #Flu #ClinicalResearch